These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1963 related items for PubMed ID: 18375475

  • 1. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA, Onuigbo NT.
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [Abstract] [Full Text] [Related]

  • 2. Renal failure and concurrent RAAS blockade in older CKD patients with renal artery stenosis: an extended Mayo Clinic prospective 63-month experience.
    Onuigbo MA, Onuigbo NT.
    Ren Fail; 2008 Jul; 30(4):363-71. PubMed ID: 18569908
    [Abstract] [Full Text] [Related]

  • 3. Late onset azotemia from RAAS blockade in CKD patients with normal renal arteries and no precipitating risk factors.
    Onuigbo MA, Onuigbo NT.
    Ren Fail; 2008 Jul; 30(1):73-80. PubMed ID: 18197547
    [Abstract] [Full Text] [Related]

  • 4. Does renin-angiotensin aldosterone system blockade exacerbate contrast-induced nephropathy in patients with chronic kidney disease? A prospective 50-month Mayo Clinic study.
    Onuigbo MA, Onuigbo NT.
    Ren Fail; 2008 Jul; 30(1):67-72. PubMed ID: 18197546
    [Abstract] [Full Text] [Related]

  • 5. Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients?--Three cases of severe acute renal failure encountered in a northwestern Wisconsin Nephrology practice.
    Onuigbo MA.
    Hemodial Int; 2009 Oct; 13 Suppl 1():S24-9. PubMed ID: 19775421
    [Abstract] [Full Text] [Related]

  • 6. Late onset renal failure from angiotensin blockade (LORFFAB): a prospective thirty-month Mayo Health System clinic experience.
    Onuigbo MA, Onuigbo NT.
    Med Sci Monit; 2005 Oct; 11(10):CR462-9. PubMed ID: 16192897
    [Abstract] [Full Text] [Related]

  • 7. Late-onset renal failure from angiotensin blockade (LORFFAB) in 100 CKD patients.
    Onuigbo MA, Onuigbo NT.
    Int Urol Nephrol; 2008 Oct; 40(1):233-9. PubMed ID: 18196471
    [Abstract] [Full Text] [Related]

  • 8. Untoward effects of chronic dual renin-angiotensin system blockade: influence of previous chronic renal failure.
    Robles NR, Cancho B, Barroso S, Martín MV, Sánchez Casado E.
    Int J Clin Pract; 2006 Sep; 60(9):1035-9. PubMed ID: 16939543
    [Abstract] [Full Text] [Related]

  • 9. The natural history of chronic kidney disease revisited--a 72-month Mayo Health System Hypertension Clinic practice-based research network prospective report on end-stage renal disease and death rates in 100 high-risk chronic kidney disease patients: a call for circumspection.
    Onuigbo MA.
    Adv Perit Dial; 2009 Sep; 25():85-8. PubMed ID: 19886324
    [Abstract] [Full Text] [Related]

  • 10. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.
    Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651
    [Abstract] [Full Text] [Related]

  • 11. Syndrome of rapid-onset end-stage renal disease: a new unrecognized pattern of CKD progression to ESRD.
    Onuigbo MA.
    Ren Fail; 2010 Oct 20; 32(8):954-8. PubMed ID: 20722563
    [Abstract] [Full Text] [Related]

  • 12. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y, Nagasawa Y, Tomida K, Mikami S, Kaneko T, Okada N, Tsubakihara Y, Imai E, Shoji T.
    Hypertens Res; 2008 Jan 20; 31(1):59-67. PubMed ID: 18360019
    [Abstract] [Full Text] [Related]

  • 13. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.
    Weir MR, Rolfe M.
    Clin J Am Soc Nephrol; 2010 Mar 20; 5(3):531-48. PubMed ID: 20150448
    [Abstract] [Full Text] [Related]

  • 14. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L, Kocks MJ, Laverman GD, Navis G.
    Minerva Med; 2004 Oct 20; 95(5):395-409. PubMed ID: 15467515
    [Abstract] [Full Text] [Related]

  • 15. Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
    Balamuthusamy S, Srinivasan L, Verma M, Adigopula S, Jalandhara N, Hathiwala S, Smith E.
    Am Heart J; 2008 May 20; 155(5):791-805. PubMed ID: 18440325
    [Abstract] [Full Text] [Related]

  • 16. Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trial.
    Kiski D, Stepper W, Brand E, Breithardt G, Reinecke H.
    Nephrol Dial Transplant; 2010 Mar 20; 25(3):759-64. PubMed ID: 19903660
    [Abstract] [Full Text] [Related]

  • 17. Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan.
    Hwang SJ, Lin MY, Chen HC, Hwang SC, Yang WC, Hsu CC, Chiu HC, Mau LW.
    Nephrol Dial Transplant; 2008 Oct 20; 23(10):3192-8. PubMed ID: 18450830
    [Abstract] [Full Text] [Related]

  • 18. Long-term renal function preservation after renal artery stenting in patients with progressive ischemic nephropathy.
    Rocha-Singh KJ, Ahuja RK, Sung CH, Rutherford J.
    Catheter Cardiovasc Interv; 2002 Oct 20; 57(2):135-41. PubMed ID: 12357507
    [Abstract] [Full Text] [Related]

  • 19. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
    Levin A, Djurdjev O, Beaulieu M, Er L.
    Am J Kidney Dis; 2008 Oct 20; 52(4):661-71. PubMed ID: 18805347
    [Abstract] [Full Text] [Related]

  • 20. Pulse pressure and inhibition of renin-angiotensin system in chronic kidney disease.
    Banerjee D, Brincat S, Gregson H, Contreras G, Streather C, Oliveira D, Nelson S.
    Nephrol Dial Transplant; 2006 Apr 20; 21(4):975-8. PubMed ID: 16384830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 99.